View ValuationWeihai Guangwei Composites 향후 성장Future 기준 점검 1/6Weihai Guangwei Composites (는) 각각 연간 18.6% 및 12.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 18.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 13.6% 로 예상됩니다.핵심 정보18.6%이익 성장률18.41%EPS 성장률Chemicals 이익 성장28.8%매출 성장률12.4%향후 자기자본이익률13.59%애널리스트 커버리지Low마지막 업데이트15 Jun 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Jul 17Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥24.39, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 12% over the past three years.공고 • Jun 30Weihai Guangwei Composites Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2026 results on Aug 25, 2026공고 • Apr 24Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Weihai, Shandong China공고 • Mar 31Weihai Guangwei Composites Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026공고 • Dec 31Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026공고 • Sep 30Weihai Guangwei Composites Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025공고 • Jul 02Weihai Guangwei Composites Co., Ltd. to Report First Half, 2025 Results on Aug 19, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2025 results on Aug 19, 2025공고 • Apr 23Weihai Guangwei Composites Co., Ltd. Approves Cash Dividend for 2024Weihai Guangwei Composites Co., Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 5.00000000 per 10 shares (tax included) for 2024.공고 • Apr 02Weihai Guangwei Composites Co., Ltd. Announces Profit Distribution Proposal for the Year 2024Weihai Guangwei Composites Co., Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 5.00000 for the year 2024.공고 • Apr 01Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: No. 130, Tianjin Road, Gaoqu, Weihai, Shandong China공고 • Mar 31Weihai Guangwei Composites Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025공고 • Dec 31Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2024 Results on Apr 22, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2024 results on Apr 22, 2025Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.30 (vs CN¥0.25 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.25 in 3Q 2023). Revenue: CN¥746.3m (up 43% from 3Q 2023). Net income: CN¥246.7m (up 19% from 3Q 2023). Profit margin: 33% (down from 40% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 28%After last week's 28% share price gain to CN¥32.92, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 16% over the past three years.공고 • Sep 30Weihai Guangwei Composites Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.29 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.26 (down from CN¥0.29 in 2Q 2023). Revenue: CN¥644.5m (down 3.4% from 2Q 2023). Net income: CN¥211.0m (down 13% from 2Q 2023). Profit margin: 33% (down from 36% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.공고 • Jun 29Weihai Guangwei Composites Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2024 results on Aug 27, 2024공고 • Jun 26Weihai Guangwei Composites Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 03 July 2024Weihai Guangwei Composites Co., Ltd. announced final cash dividend of CNY 5.00 per 10 shares on A shares (tax included) for the year 2023. Record date: 02 July 2024, Ex-date: 03 July 2024 and Payment date: 03 July 2024.Reported Earnings • Apr 29First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.21 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 1Q 2023). Revenue: CN¥511.6m (down 8.1% from 1Q 2023). Net income: CN¥157.3m (down 8.2% from 1Q 2023). Profit margin: 31% (in line with 1Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.공고 • Apr 10+ 1 more updateWeihai Guangwei Composites Co., Ltd., Annual General Meeting, May 10, 2024Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 10, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Weihai, Shandong China Agenda: To consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider 2023 annual report and its summary; to consider Shareholder return plan for the next three years; to consider Remuneration plan for directors and supervisors; to consider Connected transactions regarding guarantee and financial aid to controlled subsidiaries; to consider Application for comprehensive credit line to banks and other financial institutions, bank loans and relevant guarantee by the Company and its subsidiaries; and to consider Reappointment of 2024 audit firm.Reported Earnings • Apr 09Full year 2023 earnings released: EPS: CN¥1.05 (vs CN¥1.13 in FY 2022)Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥873.2m (down 6.5% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.공고 • Mar 30Weihai Guangwei Composites Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024Buy Or Sell Opportunity • Mar 22Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 18% to CN¥31.36. The fair value is estimated to be CN¥25.59, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 9.3%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 47% in the next 2 years.Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥27.24, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.67 per share.Reported Earnings • Jan 30Full year 2023 earnings released: EPS: CN¥1.05 (vs CN¥1.13 in FY 2022)Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥869.1m (down 7.0% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.공고 • Jan 01Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces an Equity Buyback for CNY 300 million worth of its shares.Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces a share repurchase program. Under the program, the company will repurchase up to CNY 300 million worth of its Class A shares. The shares will be repurchased at no more than CNY 37.35 per share. The purpose of the program is to maintain company value and shareholder rights. The plan will be valid for 3 months.공고 • Dec 30Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2023 Results on Apr 09, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2023 results on Apr 09, 2024Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥26.53, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥27.13 per share.Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.29 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.25 (down from CN¥0.29 in 3Q 2022). Revenue: CN¥523.2m (down 16% from 3Q 2022). Net income: CN¥208.0m (down 15% from 3Q 2022). Profit margin: 40% (in line with 3Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 15Second quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.36 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.36 in 2Q 2022). Revenue: CN¥666.9m (down 7.8% from 2Q 2022). Net income: CN¥241.8m (down 19% from 2Q 2022). Profit margin: 36% (down from 41% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.공고 • Jul 01Weihai Guangwei Composites Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2023 results on Aug 15, 2023Upcoming Dividend • May 04Upcoming dividend of CN¥0.70 per share at 1.3% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 11 May 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 1.3%. Lower than top quartile of Chinese dividend payers (1.9%). Lower than average of industry peers (1.9%).Valuation Update With 7 Day Price Move • Apr 03Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥51.06, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥34.88 per share.Reported Earnings • Mar 29Full year 2022 earnings released: EPS: CN¥1.80 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.51b (down 3.7% from FY 2021). Net income: CN¥934.3m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jan 12Full year 2022 earnings released: EPS: CN¥1.80 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.52b (down 3.4% from FY 2021). Net income: CN¥931.9m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.35 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.47 (up from CN¥0.35 in 3Q 2021). Revenue: CN¥625.8m (down 7.9% from 3Q 2021). Net income: CN¥244.7m (up 33% from 3Q 2021). Profit margin: 39% (up from 27% in 3Q 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.42 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.42 in 2Q 2021). Revenue: CN¥723.6m (up 9.9% from 2Q 2021). Net income: CN¥298.1m (up 38% from 2Q 2021). Profit margin: 41% (up from 33% in 2Q 2021). The increase in margin was primarily driven by higher revenue. Over the next year, revenue is forecast to grow 36%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥68.39, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 92% over the past three years.Valuation Update With 7 Day Price Move • May 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥49.81, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥22.42 per share.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.42 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.42 in 1Q 2021). Revenue: CN¥590.9m (down 5.5% from 1Q 2021). Net income: CN¥207.5m (down 5.0% from 1Q 2021). Profit margin: 35% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 36%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Independent Director Wenguang Tian is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Apr 14Full year 2021 earnings released: EPS: CN¥1.46 (vs CN¥1.24 in FY 2020)Full year 2021 results: EPS: CN¥1.46 (up from CN¥1.24 in FY 2020). Revenue: CN¥2.61b (up 23% from FY 2020). Net income: CN¥758.4m (up 18% from FY 2020). Profit margin: 29% (down from 30% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 29%, compared to a 53% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.33 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥679.3m (up 14% from 3Q 2020). Net income: CN¥184.2m (up 6.7% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.35 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥658.4m (up 27% from 2Q 2020). Net income: CN¥215.6m (up 20% from 2Q 2020). Profit margin: 33% (down from 35% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥79.91, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years.Reported Earnings • Apr 25First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.33 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥625.0m (up 28% from 1Q 2020). Net income: CN¥218.5m (up 27% from 1Q 2020). Profit margin: 35% (in line with 1Q 2020).Reported Earnings • Mar 30Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.7m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019).Is New 90 Day High Low • Mar 01New 90-day low: CN¥72.78The company is down 2.0% from its price of CN¥74.54 on 01 December 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥12.20 per share.Valuation Update With 7 Day Price Move • Feb 23Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥74.59, the stock is trading at a trailing P/E ratio of 60.2x, down from the previous P/E ratio of 73x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past year are 33%.Reported Earnings • Feb 02Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.6m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019).Analyst Estimate Surprise Post Earnings • Feb 02Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 24%, compared to a 51% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Dec 25Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥89.09, the stock is trading at a trailing P/E ratio of 76.8x, up from the previous P/E ratio of 66.7x. This compares to an average P/E of 34x in the Chemicals industry in China. Total returns to shareholders over the past year are 97%.Is New 90 Day High Low • Dec 21New 90-day high: CN¥82.30The company is up 15% from its price of CN¥71.70 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥8.63 per share.Is New 90 Day High Low • Oct 30New 90-day low: CN¥66.07The company is down 15% from its price of CN¥77.55 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥9.38 per share.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥602.0m, up 18% from the prior year. Total revenue was CN¥2.01b over the last 12 months, up 19% from the prior year.Analyst Estimate Surprise Post Earnings • Oct 28Third-quarter earnings released: Revenue beats expectationsThird-quarter revenue exceeded analyst estimates by 2.9% at CN¥598.4m. Revenue is forecast to grow 24% over the next year, compared to a 44% growth forecast for the Chemicals industry in China.이익 및 매출 성장 예측XSEC:300699 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20284,098995N/A1,615412/31/20273,705889N/A1,261412/31/20263,191763N/A93733/31/20262,9335704151,140N/A12/31/20252,8606035481,295N/A9/30/20252,5345413661,048N/A6/30/20252,49564264805N/A3/31/20252,5047393481,262N/A12/31/20242,45074124863N/A9/30/20242,673867-445405N/A6/30/20242,450828-355544N/A3/31/20242,473859-395357N/A12/31/20232,518873-210534N/A9/30/20232,318805-235518N/A6/30/20232,42084243764N/A3/31/20232,477898-530219N/A1/1/20232,511934-551147N/A9/30/20222,5858905961,122N/A6/30/20222,6388305651,095N/A3/31/20222,5737476621,218N/A1/1/20222,6077585951,196N/A9/30/20212,47573679731N/A6/30/20212,394724-94633N/A3/31/20212,253689223889N/A12/31/20202,116642375956N/A9/30/20202,009602-186374N/A6/30/20201,88456338435N/A3/31/20201,768535169531N/A12/31/20191,715522N/A753N/A9/30/20191,689510N/A636N/A6/30/20191,549472N/A637N/A3/31/20191,527448N/A359N/A12/31/20181,364377N/A237N/A9/30/20181,196340N/A414N/A6/30/20181,109299N/A331N/A3/31/20181,008259N/A313N/A12/31/2017949237N/A418N/A9/30/2017934297N/A195N/A12/31/2016633199N/A21N/A12/31/2015543180N/A203N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 300699 의 연간 예상 수익 증가율(18.6%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 300699 의 연간 수익(18.6%)이 CN 시장(26.1%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 300699 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 300699 의 수익(연간 12.4%)이 CN 시장(연간 16.1%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 300699 의 수익(연간 12.4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 300699의 자본 수익률은 3년 후 13.6%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/23 20:50종가2026/07/23 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Weihai Guangwei Composites Co., Ltd.는 8명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yan ChenChina International Capital Corporation LimitedChenshuo FuCitic Securities Co., Ltd.Yan LinGoldman Sachs5명의 분석가 더 보기
Valuation Update With 7 Day Price Move • Jul 17Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥24.39, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 12% over the past three years.
공고 • Jun 30Weihai Guangwei Composites Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2026 results on Aug 25, 2026
공고 • Apr 24Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Weihai, Shandong China
공고 • Mar 31Weihai Guangwei Composites Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
공고 • Dec 31Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
공고 • Sep 30Weihai Guangwei Composites Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025
공고 • Jul 02Weihai Guangwei Composites Co., Ltd. to Report First Half, 2025 Results on Aug 19, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2025 results on Aug 19, 2025
공고 • Apr 23Weihai Guangwei Composites Co., Ltd. Approves Cash Dividend for 2024Weihai Guangwei Composites Co., Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 5.00000000 per 10 shares (tax included) for 2024.
공고 • Apr 02Weihai Guangwei Composites Co., Ltd. Announces Profit Distribution Proposal for the Year 2024Weihai Guangwei Composites Co., Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 5.00000 for the year 2024.
공고 • Apr 01Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: No. 130, Tianjin Road, Gaoqu, Weihai, Shandong China
공고 • Mar 31Weihai Guangwei Composites Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025
공고 • Dec 31Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2024 Results on Apr 22, 2025Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2024 results on Apr 22, 2025
Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.30 (vs CN¥0.25 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.25 in 3Q 2023). Revenue: CN¥746.3m (up 43% from 3Q 2023). Net income: CN¥246.7m (up 19% from 3Q 2023). Profit margin: 33% (down from 40% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 28%After last week's 28% share price gain to CN¥32.92, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 16% over the past three years.
공고 • Sep 30Weihai Guangwei Composites Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024
Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.29 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.26 (down from CN¥0.29 in 2Q 2023). Revenue: CN¥644.5m (down 3.4% from 2Q 2023). Net income: CN¥211.0m (down 13% from 2Q 2023). Profit margin: 33% (down from 36% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
공고 • Jun 29Weihai Guangwei Composites Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2024 results on Aug 27, 2024
공고 • Jun 26Weihai Guangwei Composites Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 03 July 2024Weihai Guangwei Composites Co., Ltd. announced final cash dividend of CNY 5.00 per 10 shares on A shares (tax included) for the year 2023. Record date: 02 July 2024, Ex-date: 03 July 2024 and Payment date: 03 July 2024.
Reported Earnings • Apr 29First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.21 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 1Q 2023). Revenue: CN¥511.6m (down 8.1% from 1Q 2023). Net income: CN¥157.3m (down 8.2% from 1Q 2023). Profit margin: 31% (in line with 1Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
공고 • Apr 10+ 1 more updateWeihai Guangwei Composites Co., Ltd., Annual General Meeting, May 10, 2024Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 10, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Weihai, Shandong China Agenda: To consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider 2023 annual report and its summary; to consider Shareholder return plan for the next three years; to consider Remuneration plan for directors and supervisors; to consider Connected transactions regarding guarantee and financial aid to controlled subsidiaries; to consider Application for comprehensive credit line to banks and other financial institutions, bank loans and relevant guarantee by the Company and its subsidiaries; and to consider Reappointment of 2024 audit firm.
Reported Earnings • Apr 09Full year 2023 earnings released: EPS: CN¥1.05 (vs CN¥1.13 in FY 2022)Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥873.2m (down 6.5% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
공고 • Mar 30Weihai Guangwei Composites Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024
Buy Or Sell Opportunity • Mar 22Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 18% to CN¥31.36. The fair value is estimated to be CN¥25.59, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 9.3%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 47% in the next 2 years.
Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥27.24, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.67 per share.
Reported Earnings • Jan 30Full year 2023 earnings released: EPS: CN¥1.05 (vs CN¥1.13 in FY 2022)Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥869.1m (down 7.0% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
공고 • Jan 01Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces an Equity Buyback for CNY 300 million worth of its shares.Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces a share repurchase program. Under the program, the company will repurchase up to CNY 300 million worth of its Class A shares. The shares will be repurchased at no more than CNY 37.35 per share. The purpose of the program is to maintain company value and shareholder rights. The plan will be valid for 3 months.
공고 • Dec 30Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2023 Results on Apr 09, 2024Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2023 results on Apr 09, 2024
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥26.53, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥27.13 per share.
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.29 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.25 (down from CN¥0.29 in 3Q 2022). Revenue: CN¥523.2m (down 16% from 3Q 2022). Net income: CN¥208.0m (down 15% from 3Q 2022). Profit margin: 40% (in line with 3Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 15Second quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.36 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.36 in 2Q 2022). Revenue: CN¥666.9m (down 7.8% from 2Q 2022). Net income: CN¥241.8m (down 19% from 2Q 2022). Profit margin: 36% (down from 41% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
공고 • Jul 01Weihai Guangwei Composites Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2023 results on Aug 15, 2023
Upcoming Dividend • May 04Upcoming dividend of CN¥0.70 per share at 1.3% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 11 May 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 1.3%. Lower than top quartile of Chinese dividend payers (1.9%). Lower than average of industry peers (1.9%).
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥51.06, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥34.88 per share.
Reported Earnings • Mar 29Full year 2022 earnings released: EPS: CN¥1.80 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.51b (down 3.7% from FY 2021). Net income: CN¥934.3m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jan 12Full year 2022 earnings released: EPS: CN¥1.80 (vs CN¥1.46 in FY 2021)Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.52b (down 3.4% from FY 2021). Net income: CN¥931.9m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.35 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.47 (up from CN¥0.35 in 3Q 2021). Revenue: CN¥625.8m (down 7.9% from 3Q 2021). Net income: CN¥244.7m (up 33% from 3Q 2021). Profit margin: 39% (up from 27% in 3Q 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.42 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.42 in 2Q 2021). Revenue: CN¥723.6m (up 9.9% from 2Q 2021). Net income: CN¥298.1m (up 38% from 2Q 2021). Profit margin: 41% (up from 33% in 2Q 2021). The increase in margin was primarily driven by higher revenue. Over the next year, revenue is forecast to grow 36%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥68.39, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 92% over the past three years.
Valuation Update With 7 Day Price Move • May 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥49.81, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥22.42 per share.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.42 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.42 in 1Q 2021). Revenue: CN¥590.9m (down 5.5% from 1Q 2021). Net income: CN¥207.5m (down 5.0% from 1Q 2021). Profit margin: 35% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 36%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Independent Director Wenguang Tian is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Apr 14Full year 2021 earnings released: EPS: CN¥1.46 (vs CN¥1.24 in FY 2020)Full year 2021 results: EPS: CN¥1.46 (up from CN¥1.24 in FY 2020). Revenue: CN¥2.61b (up 23% from FY 2020). Net income: CN¥758.4m (up 18% from FY 2020). Profit margin: 29% (down from 30% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 29%, compared to a 53% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.33 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥679.3m (up 14% from 3Q 2020). Net income: CN¥184.2m (up 6.7% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.35 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥658.4m (up 27% from 2Q 2020). Net income: CN¥215.6m (up 20% from 2Q 2020). Profit margin: 33% (down from 35% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥79.91, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years.
Reported Earnings • Apr 25First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.33 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥625.0m (up 28% from 1Q 2020). Net income: CN¥218.5m (up 27% from 1Q 2020). Profit margin: 35% (in line with 1Q 2020).
Reported Earnings • Mar 30Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.7m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019).
Is New 90 Day High Low • Mar 01New 90-day low: CN¥72.78The company is down 2.0% from its price of CN¥74.54 on 01 December 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥12.20 per share.
Valuation Update With 7 Day Price Move • Feb 23Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥74.59, the stock is trading at a trailing P/E ratio of 60.2x, down from the previous P/E ratio of 73x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past year are 33%.
Reported Earnings • Feb 02Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.6m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019).
Analyst Estimate Surprise Post Earnings • Feb 02Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 24%, compared to a 51% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Dec 25Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥89.09, the stock is trading at a trailing P/E ratio of 76.8x, up from the previous P/E ratio of 66.7x. This compares to an average P/E of 34x in the Chemicals industry in China. Total returns to shareholders over the past year are 97%.
Is New 90 Day High Low • Dec 21New 90-day high: CN¥82.30The company is up 15% from its price of CN¥71.70 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥8.63 per share.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥66.07The company is down 15% from its price of CN¥77.55 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥9.38 per share.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥602.0m, up 18% from the prior year. Total revenue was CN¥2.01b over the last 12 months, up 19% from the prior year.
Analyst Estimate Surprise Post Earnings • Oct 28Third-quarter earnings released: Revenue beats expectationsThird-quarter revenue exceeded analyst estimates by 2.9% at CN¥598.4m. Revenue is forecast to grow 24% over the next year, compared to a 44% growth forecast for the Chemicals industry in China.